DK1765355T3 - Benzoxazin til behandling af luftvejslidelser - Google Patents
Benzoxazin til behandling af luftvejslidelserInfo
- Publication number
- DK1765355T3 DK1765355T3 DK05740045.9T DK05740045T DK1765355T3 DK 1765355 T3 DK1765355 T3 DK 1765355T3 DK 05740045 T DK05740045 T DK 05740045T DK 1765355 T3 DK1765355 T3 DK 1765355T3
- Authority
- DK
- Denmark
- Prior art keywords
- benzoxazine
- treatment
- respiratory disorders
- respiratory
- disorders
- Prior art date
Links
- CMLFRMDBDNHMRA-UHFFFAOYSA-N 2h-1,2-benzoxazine Chemical compound C1=CC=C2C=CNOC2=C1 CMLFRMDBDNHMRA-UHFFFAOYSA-N 0.000 title 1
- 208000023504 respiratory system disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004019539A DE102004019539A1 (de) | 2004-04-22 | 2004-04-22 | Neue Arzneimittel zur Behandlung von Atemwegserkrankungen |
| PCT/EP2005/004075 WO2005102350A1 (de) | 2004-04-22 | 2005-04-18 | Benzoxazine zur behandlung von atemwegserkrankungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1765355T3 true DK1765355T3 (da) | 2013-04-08 |
Family
ID=34966948
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05740045.9T DK1765355T3 (da) | 2004-04-22 | 2005-04-18 | Benzoxazin til behandling af luftvejslidelser |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1765355B1 (da) |
| JP (1) | JP2007533684A (da) |
| KR (2) | KR20130042662A (da) |
| CN (1) | CN1946406A (da) |
| AU (1) | AU2005235420C1 (da) |
| BR (1) | BRPI0510084A (da) |
| CA (1) | CA2559700C (da) |
| DE (1) | DE102004019539A1 (da) |
| DK (1) | DK1765355T3 (da) |
| EA (1) | EA012045B1 (da) |
| EC (1) | ECSP066948A (da) |
| ES (1) | ES2403184T3 (da) |
| IL (1) | IL177663A (da) |
| NO (1) | NO20065061L (da) |
| NZ (1) | NZ551272A (da) |
| PL (1) | PL1765355T3 (da) |
| SG (1) | SG152233A1 (da) |
| UA (1) | UA85707C2 (da) |
| WO (1) | WO2005102350A1 (da) |
| ZA (1) | ZA200606547B (da) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7056916B2 (en) | 2002-11-15 | 2006-06-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments for the treatment of chronic obstructive pulmonary disease |
| US7220742B2 (en) | 2004-05-14 | 2007-05-22 | Boehringer Ingelheim International Gmbh | Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments |
| DE102004024452A1 (de) * | 2004-05-14 | 2005-12-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosolformulierung für die Inhalation von Betaagonisten |
| CN101208316B (zh) | 2005-08-15 | 2012-05-09 | 贝林格尔·英格海姆国际有限公司 | 制备β-模拟物的方法 |
| BRPI0618370A2 (pt) * | 2005-11-09 | 2011-08-30 | Boehringer Ingelheim Int | formulação aerossol de medicamento, uso do mesmo e kit de inalação |
| GB0601951D0 (en) | 2006-01-31 | 2006-03-15 | Novartis Ag | Organic compounds |
| MX2010007604A (es) | 2008-01-11 | 2010-08-02 | Novartis Ag | Pirimidinas como inhibidores de cinasa. |
| WO2012034095A1 (en) | 2010-09-09 | 2012-03-15 | Irm Llc | Compounds and compositions as trk inhibitors |
| US8637516B2 (en) | 2010-09-09 | 2014-01-28 | Irm Llc | Compounds and compositions as TRK inhibitors |
| WO2012116217A1 (en) | 2011-02-25 | 2012-08-30 | Irm Llc | Compounds and compositions as trk inhibitors |
| US9784726B2 (en) | 2013-01-08 | 2017-10-10 | Atrogi Ab | Screening method, a kit, a method of treatment and a compound for use in a method of treatment |
| WO2018108669A1 (en) | 2016-12-12 | 2018-06-21 | Boehringer Ingelheim International Gmbh | Nintedanib for use in methods for the treatment of interstitial lung diseases by coadministration with olodaterol |
| GB201714736D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714740D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714745D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714734D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201903832D0 (en) | 2019-03-20 | 2019-05-01 | Atrogi Ab | New compounds and methods |
| GB202205895D0 (en) | 2022-04-22 | 2022-06-08 | Atrogi Ab | New medical uses |
| EP4651867A1 (en) | 2023-01-20 | 2025-11-26 | Atrogi AB | Beta 2-adrenergic receptor agonists for treatment or prevention of muscle wasting |
| GB202302225D0 (en) | 2023-02-16 | 2023-04-05 | Atrogi Ab | New medical uses |
| GB202303229D0 (en) | 2023-03-06 | 2023-04-19 | Atrogi Ab | New medical uses |
| GB202403169D0 (en) | 2024-03-05 | 2024-04-17 | Atrogi Ab | New medical uses |
| WO2025238248A1 (en) | 2024-05-17 | 2025-11-20 | Atrogi Ab | USE OF β2-ADRENERGIC RECEPTOR AGONISTS IN TREATING MUSCLE WASTING |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4460581A (en) * | 1982-10-12 | 1984-07-17 | Boehringer Ingelheim Kg | (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones |
| BR0110331A (pt) * | 2000-04-27 | 2003-01-07 | Boehringer Ingelheim Pharma | Substâncias que mimetizam beta que têm uma atividade de longa duração, processos para prepará-las e o uso das mesmas como medicamentos |
| DE10130371A1 (de) * | 2001-06-23 | 2003-01-02 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika |
| DE10253282A1 (de) * | 2002-11-15 | 2004-05-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung |
-
2004
- 2004-04-22 DE DE102004019539A patent/DE102004019539A1/de not_active Withdrawn
-
2005
- 2005-04-18 JP JP2007508807A patent/JP2007533684A/ja active Pending
- 2005-04-18 UA UAA200612036A patent/UA85707C2/ru unknown
- 2005-04-18 SG SG200902504-0A patent/SG152233A1/en unknown
- 2005-04-18 KR KR1020137008584A patent/KR20130042662A/ko not_active Ceased
- 2005-04-18 ES ES05740045T patent/ES2403184T3/es not_active Expired - Lifetime
- 2005-04-18 NZ NZ551272A patent/NZ551272A/en not_active IP Right Cessation
- 2005-04-18 WO PCT/EP2005/004075 patent/WO2005102350A1/de not_active Ceased
- 2005-04-18 EP EP05740045A patent/EP1765355B1/de not_active Expired - Lifetime
- 2005-04-18 DK DK05740045.9T patent/DK1765355T3/da active
- 2005-04-18 CA CA2559700A patent/CA2559700C/en not_active Expired - Lifetime
- 2005-04-18 KR KR1020067024543A patent/KR101338947B1/ko not_active Expired - Fee Related
- 2005-04-18 PL PL05740045T patent/PL1765355T3/pl unknown
- 2005-04-18 AU AU2005235420A patent/AU2005235420C1/en not_active Ceased
- 2005-04-18 CN CNA200580012623XA patent/CN1946406A/zh active Pending
- 2005-04-18 BR BRPI0510084-4A patent/BRPI0510084A/pt not_active IP Right Cessation
- 2005-04-18 EA EA200601837A patent/EA012045B1/ru not_active IP Right Cessation
-
2006
- 2006-08-07 ZA ZA200606547A patent/ZA200606547B/xx unknown
- 2006-08-23 IL IL177663A patent/IL177663A/en not_active IP Right Cessation
- 2006-10-23 EC EC2006006948A patent/ECSP066948A/es unknown
- 2006-11-02 NO NO20065061A patent/NO20065061L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20070054599A (ko) | 2007-05-29 |
| JP2007533684A (ja) | 2007-11-22 |
| NO20065061L (no) | 2006-11-07 |
| ZA200606547B (en) | 2008-04-30 |
| SG152233A1 (en) | 2009-05-29 |
| IL177663A0 (en) | 2006-12-31 |
| IL177663A (en) | 2014-04-30 |
| EP1765355B1 (de) | 2013-03-06 |
| CA2559700C (en) | 2013-06-11 |
| ES2403184T3 (es) | 2013-05-16 |
| KR101338947B1 (ko) | 2013-12-10 |
| WO2005102350A1 (de) | 2005-11-03 |
| AU2005235420C1 (en) | 2011-02-24 |
| UA85707C2 (ru) | 2009-02-25 |
| ECSP066948A (es) | 2006-12-20 |
| CN1946406A (zh) | 2007-04-11 |
| EA012045B1 (ru) | 2009-08-28 |
| AU2005235420A1 (en) | 2005-11-03 |
| DE102004019539A1 (de) | 2005-11-10 |
| BRPI0510084A (pt) | 2007-10-16 |
| PL1765355T3 (pl) | 2013-08-30 |
| CA2559700A1 (en) | 2005-11-03 |
| AU2005235420B2 (en) | 2010-10-28 |
| NZ551272A (en) | 2010-10-29 |
| EA200601837A1 (ru) | 2007-04-27 |
| KR20130042662A (ko) | 2013-04-26 |
| EP1765355A1 (de) | 2007-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1765355T3 (da) | Benzoxazin til behandling af luftvejslidelser | |
| DK2019683T4 (da) | Indgivelse af vækstfaktorer til behandling af CNS-lidelser | |
| DK2474321T3 (da) | Sammensætninger til behandling af collagenmedierede sygdomme | |
| DK3456707T3 (da) | 4-(p-quinonyl)-2-hydroxybutanamidderivater til behandling af mitokondriesygdomme | |
| DK1828164T3 (da) | Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider | |
| DK1778668T3 (da) | Fremgangsmåde til fremstilling af dihydropteridion | |
| DK1730119T3 (da) | Imidazolforbindelser til behandling af neurodegenerative forstyrrelser | |
| DK1874781T3 (da) | Dihydrothienopyrimidiner til behandling af inflammatoriske sygdomme | |
| DK1869025T6 (da) | Piperazin-substituerede benzothiophener til behandling af mentale lidelser | |
| DK1984357T3 (da) | 2,4-pyrimidindiaminforbindelser til behandling eller forebyggelse af autoimmunsygdomme | |
| DK2102169T3 (da) | Indazolylamidderivater til behandling af glucocorticoidreceptormedierede forstyrrelser | |
| DK1830843T3 (da) | Indolidon-derivater til behandling eller forebyggelse af fibrotiske sygdomme | |
| DK1708992T3 (da) | Sulfonamidderivater til behandling af sygdomme | |
| LTC1781298I2 (lt) | Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui | |
| DK1830850T3 (da) | Quinolin-derivater til behandling af latent tuberkulose | |
| DK1720571T3 (da) | Fremgangsmåde til behandling af hæmolytisk sygdom | |
| DK1928438T3 (da) | Anvendelse af ibudilast til behandling af stofafhængighed | |
| DK1817282T3 (da) | Til behandling af respiratoriske sygdomme egnede phenoxy derivater | |
| DK1937633T3 (da) | Biphenyloxyeddikesyrederivater til behandling af respiratoriske sygdomme | |
| DK1708991T3 (da) | Sulfonamid derivater til behandling af sygdomme | |
| DK1868600T3 (da) | Spirocyklisk cyclohexanderivat til behandling af stofafhængighed | |
| DK2041093T3 (da) | Til behandling af GPR38-receptor medierede sygdomme anvendelige piperazinylderivativer | |
| DK1685834T3 (da) | Anvendelse af pinolensyre til behandling af obesitet | |
| DK3403657T3 (da) | Anvendelse af oligouronater til behandling af slimhyperviskositet | |
| DK1948176T3 (da) | Diarylurinstoffer til behandling af pulmonær hypertension |